Home
Teikoku Pharma

Teikoku Pharma Market Share Analysis for July 2026

Teikoku Pharma USA is a pharmaceutical company focused on the drug development and delivery of treatments for CNS, Pain Management and Oncology. Read more.

Industry: N/A

Domainteikokuusa.com

Year Founded1997

Employees51 - 200

Annual Revenue$15M - $25M

Teikoku Pharma

Teikoku Pharma (including company regionals)

teikokuusa.com

See more website traffic and engagement information

Teikoku Pharma Revenue up to July 2026 is 15M - 25M

revenue generated by Teikoku Pharma top domains

Teikoku Pharma top domains revenue over 3 years

Revenue for Teikoku Pharma top domains

teikokuusa.com15M - 25M

See more with Sales Intelligence

Total visits to Teikoku Pharma's top domains

Understand Teikoku Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

teikokuusa.com519

See more with Sales Intelligence

Avg. visit duration in Teikoku Pharma's top domains

Analyze Teikoku Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

teikokuusa.com00:00:43

See more with Sales Intelligence

Avg. pageviews on Teikoku Pharma's top domains

See how Teikoku Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

teikokuusa.com1.90

See more with Sales Intelligence

Teikoku Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Teikoku Pharma

These are the website technologies, by industry, used by Teikoku Pharma top domains

Payment & Currencies (5)

Visa

Widget (4)

Twemoji

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from Teikoku Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCompany launches TPU-006.Teikoku Pharma USA announces positive topline results from Phase 2 clinical trial of TPU-006, non- opioid pain management patch in Abdominoplasty surgery.

NewsCompany recognized as Fast Track Designation for TPU-006 on Jun 21st '23.Teikoku Pharma USA, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track Designation for TPU-006 in managing postoperative pain.

NewsCompany has issues with illegal conduct due to its participation in an agreement to protect a monopoly on Lidoderm.Teikoku is accused of illegal conduct due to its participation in an agreement to protect a monopoly on Lidoderm.